PharmacyCodes



Sodium tetradecyl sulfate en es it fr

Sodium tetradecyl sulfate Brand names, Sodium tetradecyl sulfate Analogs

Sodium tetradecyl sulfate Brand Names Mixture

  • No information avaliable

Sodium tetradecyl sulfate Chemical_Formula

C14H30O4S

Sodium tetradecyl sulfate RX_link

http://www.rxlist.com/cgi/generic2/sotradecol.htm

Sodium tetradecyl sulfate fda sheet

Sodium tetradecyl sulfate msds (material safety sheet)

Sodium_tetradecyl_sulfate MSDS

Sodium tetradecyl sulfate Synthesis Reference

No information avaliable

Sodium tetradecyl sulfate Molecular Weight

294.452 g/mol

Sodium tetradecyl sulfate Melting Point

No information avaliable

Sodium tetradecyl sulfate H2O Solubility

No information avaliable

Sodium tetradecyl sulfate State

Solid

Sodium tetradecyl sulfate LogP

No information avaliable

Sodium tetradecyl sulfate Dosage Forms

Solution for intramuscular injection

Sodium tetradecyl sulfate Indication

For the treatment of small uncomplicated varicose veins of the lower extremities that show simple dilation with competent valves.

Sodium tetradecyl sulfate Pharmacology

Sodium tetradecyl sulfate is an anionic surfactant which occurs as a white, waxy solid. It is used as a sclerosing agent in sclerotherapy. Sclerotherapy is an injection of a sclerosing agent directly through the skin into a lesion and is used primarily for slow-flow vascular anomalies, particularly for venous malformation and lymphatic malformation. Intravenous injection causes intima inflammation and thrombus formation. This usually occludes the injected vein. Subsequent formation of fibrous tissue results in partial or complete vein obliteration that may or may not be permanent.

Sodium tetradecyl sulfate Absorption

No information avaliable

Sodium tetradecyl sulfate side effects and Toxicity

LD50=1250 mg/kg (Orally in rat); LD50=3 ml/kg (Skin in rat)

Sodium tetradecyl sulfate Patient Information

No information avaliable

Sodium tetradecyl sulfate Organisms Affected

Humans and other mammals